Precision Business Insights

Portfolio

Research Reports

SELECT LICENSE TYPE
Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner

Why Precision Business Insights?

  • Pre and Post Sale Support

    Get in touch with our industry experts to resolve your research queries before and after buying the report. Avail free 60 minutes analyst tele-call to get additional market information before and after purchase

  • Special Pricing and Discounts

    Avail special pricing for the purchase of report sections,regional insights, and historical data. Discounts for government bodies, research institutes, universities, NGO’s and start-up’s

  • In-depth Market Analysis

    Our research reports provides holistic market information with 360 degree analysis. We adopt 3 pronged strategy to analyze the market i.e. Secondary research , primary research, and expert validation

  • Accurate and Reliable Market Data

    Utmost focus on delivering accurate and reliable research reports. We adopt internally developed data mining tools to eliminate any data errors

  • NICHE AND GROWTH MARKETS EXPERTISE

    Proven expertise in delivering new and emerging markets product and technology advancements. We provide market information across the developed and emerging markets

  • ADHERING TO QUICK DELIVERY TIME LINES

    We provide impeccable research reports in quick turnaround time

Chronic Idiopathic Constipation (CIC) Treatment Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023


 

Available formats:    

StumbleUponEmail

Increase in the prevalence of chronic idiopathic constipation due to change in lifestyle and food habits, rise in awareness about the CIC treatment, increase in the demand for CIC drugs, and availability of the over-the-counter CIC drugs in the market are driving the chronic idiopathic constipation treatment market. Moreover, various pipeline drugs for the CIC treatment and frequent product approvals from various drug regulatory bodies are propelling the chronic idiopathic constipation treatment market. However, lack of physiological symptoms for the disease and less number of drugs available for CIC treatment are the factors anticipated to hinder the growth of Chronic Idiopathic Constipation Treatment Market

 

Global Chronic Idiopathic Constipation Treatment Market

Chronic idiopathic constipation is a functional gastrointestinal disorder which leads to difficulty in defecating. It is a more chronic or severe condition and the symptoms of the disease include bloating, abdominal discomfort, hard stool, incomplete evacuation, gastric pain, and strain during the bowel movement. It is an idiopathic condition due to the causes of the disease are unclear, however, it may cause due to psychological, neurological, and psychosomatic conditions. Chronic idiopathic constipation is majorly caused in the adults or geriatric people. Diagnosis of CIC is difficult due to the lack of physiological causes and physicians look for symptoms like weight, blood in stool, and low blood count among others.

Chronic idiopathic constipation treatment market is segmented on the basis of the drug class, route of administration, distribution mode, and distribution channel

 

Based on the drug class, Chronic idiopathic constipation treatment market is segmented into the following:

  • Emollients
  • Laxatives
  • Bulk-forming agents
  • Chloride channel activators
  • Osmotic products
  • Others

 

Based on the route of administration, Chronic idiopathic constipation treatment market is segmented into the following:

  • Oral
  • Parenteral

 

Based on the distribution mode, Chronic idiopathic constipation treatment market is segmented into the following:

  • Prescription mode
  • Over-the-counter drugs

 

Based on the distribution channel, Chronic idiopathic constipation treatment market is segmented into the following:

  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies
  • Drug Stores

 

 

Chronic idiopathic constipation Treatment market is growing at a significant CAGR owing to recent product approvals and competitors focus on the development of newer drugs for CIC treatment. Moreover, increase in the prevalence of chronic idiopathic constipation cases also expected to propel the market revenue over the forecast period. Acquisitions and mergers, product approvals, and product launchings are the key strategies adopted by the companies for increasing their revenue share in the market. For instance, In January 2017, FDA approved Tulane manufactured by Synergy Pharmaceuticals used in the treatment of chronic idiopathic constipation.

 

 

Geographically, Chronic Idiopathic Constipation Treatment Market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America has a significant share in chronic idiopathic constipation treatment market owing to increase in the prevalence if CIC disease (according to National Institute of Health, approximately 63 Mn people affected with CIC in U.S.), change in lifestyle, recent FDA approvals for CIC treatment drugs, an increase in healthcare expenditure. In Europe, increase in ageing population, rise in R&D activities for CIC treatments, availability of over-the-counter CIC drugs, an increase in per capita income might bolster the chronic idiopathic constipation treatment market. However, Asia Pacific exhibiting lucrative growth owing to the rise in geriatric population, an increase in adoption of CIC treatments.

 

 

Some of the players in Chronic Idiopathic Constipation Treatment Market are GlaxoSmithKline Plc. (U.K.), Bayer AG (Germany), Allergan Plc. (Ireland), Ironwood Pharmaceuticals, Inc. (U.S.), Astellas Pharma, Inc. (Japan), synergy pharmaceuticals, Inc. (U.S.), Sanofi S.A. (France), and  Pfizer, Inc. (U.S.) to name a few.

 

  • In September 2017, Astellas Pharma, Inc. submitted the Supplemental new drug application for Linaclotide for patients with chronic idiopathic constipation in Japan
  • In January 2017, FDA approved the Linzess for the treatment of chronic idiopathic constipation manufactured by Allergan Plc. and Ironwood Pharmaceuticals, Inc.

 

Report Outline:

  • The report provides granular level information about the market size, regional market share, and forecast from 2017-2023
  • The report covers in-detail insights about the competitor’s overview, key findings, and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments, and startup’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  1. Table of Content
  2. Executive Summary
  3. Global Chronic Idiopathic Constipation (CIC) Treatment Market Introduction
    • Global Chronic Idiopathic Constipation (CIC) Treatment Market – Taxonomy
    • Global Chronic Idiopathic Constipation (CIC) Treatment Market –Definitions
      • Drug Class
      • Route of Administration
      • Distribution Mode
      • Distribution Channel
  1. Global Chronic Idiopathic Constipation (CIC) Treatment Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Chronic Idiopathic Constipation (CIC) Treatment Market Dynamic Factors – Impact Analysis
    • Global Chronic Idiopathic Constipation (CIC) Treatment Market – Competition Landscape
    • Epidemiology
  2. Global Chronic Idiopathic Constipation (CIC) Treatment Market Analysis,2013 – 2017 and Forecast, 2018 – 2024
    • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global Chronic Idiopathic Constipation (CIC) Treatment Market, By Drug Class, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Emollients
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Laxatives
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Bulk-forming agents
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Chloride channel activators
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Osmotic products
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Chronic Idiopathic Constipation (CIC) Treatment Market Forecast, By Route of Administration,2013 – 2017 and Forecast, 2018 – 2024
    • Oral
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Parenteral
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Chronic Idiopathic Constipation (CIC) Treatment Market Forecast, By Distribution Mode, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Prescription mode
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Over-the-counter drugs
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Chronic Idiopathic Constipation (CIC) Treatment Market Forecast, By Distribution Channel, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Hospital pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Retail pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Online pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Drug Stores
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Chronic Idiopathic Constipation (CIC) Treatment Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Chronic Idiopathic Constipation (CIC) Treatment Market – Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Mode, By Distribution Channel, and Region, 2018 – 2024
  2. North America Chronic Idiopathic Constipation (CIC) Treatment MarketAnalysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Class Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Emollients
      • Laxatives
      • Bulk-forming agents
      • Chloride channel activators
      • Osmotic products
      • Others
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Mode Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription mode
      • Over-the-counter drugs
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital pharmacies
      • Retail pharmacies
      • Online pharmacies
      • Drug Stores
    • Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • S.
      • Canada
    • North America Chronic Idiopathic Constipation (CIC) Treatment Market – Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Mode, By Distribution Channel, and Country, 2018 – 2024
    • North America Chronic Idiopathic Constipation (CIC) Treatment Market Dynamics – Trends
  3. Europe Chronic Idiopathic Constipation (CIC) Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Class Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Emollients
      • Laxatives
      • Bulk-forming agents
      • Chloride channel activators
      • Osmotic products
      • Others
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Mode Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription mode
      • Over-the-counter drugs
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital pharmacies
      • Retail pharmacies
      • Online pharmacies
      • Drug Stores
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Chronic Idiopathic Constipation (CIC) Treatment Market – Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Mode, By Distribution Channel, and Country, 2018 – 2024
    • Europe Chronic Idiopathic Constipation (CIC) Treatment Market Dynamics – Trends
  4. Asia-Pacific Chronic Idiopathic Constipation (CIC) Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Class Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Emollients
      • Laxatives
      • Bulk-forming agents
      • Chloride channel activators
      • Osmotic products
      • Others
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Mode Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription mode
      • Over-the-counter drugs
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital pharmacies
      • Retail pharmacies
      • Online pharmacies
      • Drug Stores
    • Country Analysis2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Chronic Idiopathic Constipation (CIC) Treatment Market – Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Mode, By Distribution Channel, and Country, 2018 – 2024
    • Asia-Pacific Chronic Idiopathic Constipation (CIC) Treatment Market Dynamics – Trends
  5. Latin America Chronic Idiopathic Constipation (CIC) Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Class Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Emollients
      • Laxatives
      • Bulk-forming agents
      • Chloride channel activators
      • Osmotic products
      • Others
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Mode Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription mode
      • Over-the-counter drugs
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital pharmacies
      • Retail pharmacies
      • Online pharmacies
      • Drug Stores
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Chronic Idiopathic Constipation (CIC) Treatment Market – Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Mode, By Distribution Channel, and Country, 2018 – 2024
    • Latin America Chronic Idiopathic Constipation (CIC) Treatment Market Dynamics – Trends
  6. Middle East and Africa Chronic Idiopathic Constipation (CIC) Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Class Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Emollients
      • Laxatives
      • Bulk-forming agents
      • Chloride channel activators
      • Osmotic products
      • Others
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Mode Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription mode
      • Over-the-counter drugs
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital pharmacies
      • Retail pharmacies
      • Online pharmacies
      • Drug Stores
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Chronic Idiopathic Constipation (CIC) Treatment Market – Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Mode, By Distribution Channel, and Country, 2018 – 2024
    • MEA Chronic Idiopathic Constipation (CIC) Treatment Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Drug Class& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • GlaxoSmithKline Plc. (U.K.)
      • Bayer AG (Germany)
      • Allergan Plc. (Ireland)
      • Ironwood Pharmaceuticals, Inc. (U.S.)
      • Astellas Pharma, Inc. (Japan)
      • synergy pharmaceuticals, Inc. (U.S.)
      • Sanofi S.A. (France)
      • Pfizer, Inc. (U.S.)
  1. Research Methodology
  2. Key Assumptions and Acronyms

 

  1. Disclaimer: The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

Avail Discount  Up To 20%

Need more discount on this report?

Call or e-mail us for:

(U.S.) – +1-866-598-1553

Contact SalesTOLL FREE: +1-866-598-1553